Skip to main content

Advertisement

Figure 1 | Diabetology & Metabolic Syndrome

Figure 1

From: Differentiating among incretin-based therapies in the management of patients with type 2 diabetes mellitus

Figure 1

AACE/ACE diabetes algorithm for diabetes control. Algorithm for the metabolic management of type 2 diabetes. Lifestyle modification is a component of treatment for all patients. Interventions are stratified based upon the current A1C level and whether the patient is receiving treatment or is drug naïve. Medication choices are prioritized according to safety, risk of hypoglycemia, efficacy, simplicity, anticipated degree of patient adherence, and cost of medications. Only combinations of medications approved by the US Food and Drug Administration that provide complementary mechanisms of action are listed. It is essential to monitor therapy with A1C and self-monitoring of blood glucose and to adjust or advance therapy frequently (every 2 to 3 months) if the appropriate goal for each patient has not been achieved. [Reprinted from Endocrine Practice, Volume 15, Rodbard HW, Jellinger PS, Davidson JA, Einhorn D, Garber AJ, Grunberger G et al. Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control, Pages 540-559, Copyright 2009, with permission from the American Association of Clinical Endocrinologists.]

Back to article page